Burcon receives notice of allowance from the United States Patent and
Trademark Office

VANCOUVER, Sept. 29 /CNW/ - Burcon NutraScience Corporation (TSX - BU) ("Burcon" or the "Corporation") is pleased to announce today that it has received a notice of allowance from the United States Patent and Trademark Office for a patent application covering the composition of the dominant species of protein in Burcon's Puratein(R) canola protein isolate.

Puratein(R) is a cruciferin-rich canola protein isolate comprised principally of globulin proteins. The functional properties of Puratein(R) include emulsification, gel formation, thickening, formation of heat-stable foams, and water and ingredient-binding. Applications for Puratein(R) include dressings and sauces, meat substitutes, baked goods and protein bars, among many others.

Burcon's patent application which has today been allowed by the U.S. Patent and Trademark Office was originally filed on April 15th 2003 and, importantly, is a "composition of matter" patent. Burcon believes that it is developing - and has developed - a dynamic patent portfolio by aggressively seeking protection not only for its protein extraction technologies but also to protect the applications of its proteins (for example as functional ingredients in foods and beverages) and to protect the proteins themselves by filing to patent the "signature characteristics" or the "compositional matter" of its proteins. In addition, Burcon has filed patent applications to cover alternative extraction technologies, which, in Burcon's opinion, would not be commercially viable. Such filings have been made as part of Burcon's defensive strategy to gain as much protection in the protein extraction and purification space as possible.

"Today's notice of allowance from the United States Patent and Trademark Office is particularly encouraging as it is Burcon's first composition of matter patent application to have been allowed," said Johann F. Tergesen, President and Chief Operating Officer, adding, "Puratein(R) is an excellent emulsifier that can form opaque heat-induced gels and as such it can be used to replace egg protein in certain applications."

To-date, Burcon's patent portfolio consists of 92 issued patents in various countries, including 8 issued U.S. patents, and in excess of 200 additional pending patent applications, 70 of which are U.S. patent applications. Three of the 70 U.S. patent applications have now been allowed, including the patent allowance which is the subject of this news release, and will be issued as granted U.S. patents in the near future.

About Burcon NutraScience

Burcon is a leader in nutrition, health and wellness in the field of functional, renewable plant proteins. Since 1999, Burcon has developed a portfolio of composition, application, and process patents originating from our core protein extraction and purification technology. We are developing the world's first commercial canola proteins, Puratein(R) and Supertein(TM) with unique functional and nutritional attributes, and CLARISOY(TM), a revolutionary soy protein isolate which is 100% soluble and completely transparent in acidic solutions. Our team of highly specialized scientists and engineers work from our own research facility to develop and optimize environmentally sound technologies. To-date, our patent portfolio consists of 92 issued patents in various countries, including 8 issued U.S. patents, and in excess of 200 additional pending patent applications, 70 of which are U.S. patent applications.

    
    ON BEHALF OF THE BOARD OF DIRECTORS
    "Johann F. Tergesen"
    Johann F. Tergesen
    

Burcon NutraScience Corporation is a publicly listed on the Toronto Stock Exchange under the symbol "BU". For more information on Burcon, visit www.burcon.ca.

This press release contains forward-looking statements that involve risks and uncertainties. These forward-looking statements relate to, among other things, the Corporation's, plans and timing for the introduction or enhancement of our products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact. Our expectations regarding the prospect for future success depend upon our ability to develop and sell products, which we do not produce today and cannot be sold without further research and development. When used in this press release, the words "goal", "intend", "believes", "potential", "expected", "anticipates", "will be", and similar expressions, generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties. In light of the many risks and uncertainties surrounding the development of a source of protein from canola meal, you should understand that we cannot assure you that the forward looking statements contained in this press release will be realized.

SOURCE Burcon NutraScience Corporation

For further information: For further information: Jade Cheng, Chief Financial Officer, Burcon NutraScience Corporation, (604) 733-0896, (888) 408-7960 toll-free, jcheng@burcon.ca, www.burcon.ca; AXINO AG, Wolfgang Seybold, Investor Relations Europe, AXINO AG, Konigstrasse 26, 70173, Stuttgart, Germany, Tel. +49-711-25 35 92-40, Fax +49-711-25 35 92-55, wolfgang.seybold@axino.de, www.burcon.net

Organization Profile

Burcon NutraScience Corporation

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890